China Tracker - Details for China Medicine (CHME)


Warning: fopen(http://finance.yahoo.com/d/quotes.csv?s=CHME&f=snl1a2xf6): failed to open stream: HTTP request failed! HTTP/1.0 403 Forbidden in /home/fixyou/public_html/tracker_details.php on line 58

Warning: fgetcsv() expects parameter 1 to be resource, boolean given in /home/fixyou/public_html/tracker_details.php on line 60

Warning: fclose() expects parameter 1 to be resource, boolean given in /home/fixyou/public_html/tracker_details.php on line 61
 WARNING: Form 15 filed with the SEC!
 China Medicine
Shares Outstanding (MRQ): 39.59 mill 
New Shares / Dilution (TTM): 24.18 mill156.91%
Cash (MRQ): 7.85 mill0.00%
Account Receivables (MRQ): 17.27 mill0.00%
Account Receivables (Q/Q): -7.60 mill  
Long-Term Debt (MRQ): 47.60 mill0.00%
Revenue Growth (Q/Q): 2.09% 
Revenue Growth (Y/Y): -8.38%
Net Income Growth (Q/Q): -39.27% 
Net Income Growth (Y/Y): -50.64%
EPS Growth (Y/Y): -80.79%
Net Margin (Q/Q): 9.5% (15.9%)-6.40% 
Net Margin (Y/Y): 9.5% (17.5%)-8.10% 
EPS | P/E (2 MRQ Projection): $0.220.00 
CFPS | P/CF (2 MRQ Projection): -$0.190.00 
Price/Sales (2 MRQ Projection): 0.00
Price/Book (MRQ): 0.00 
Auditor: currently none
 
 Forward Projections (Fiscal Year)
EPS | P/E (Estimates updated 2010-10-31): $0.300.00 
 Basic Facts and History (show more)
Reporting Type: U.S. Company (10-K Filings) 
Going Public: Reverse Merger on 2006-02-08 

 Business Outlook

On September 26, 2012, the board of directors of China Medicine Corporation voted in favor of pursuing voluntary deregistration of the Company's common stock. The Company intends to file a Form 15 on or about October 4, 2012.

(Source: 8-K Filing, 2012-09-27)

On July 1, 2011, during the course of the on-going internal reviews by the management and the Audit Committee of the Company, the Board determined that the accounting and reporting errors at Guangzhou Konzern Medicine Co., Ltd., a wholly-owned subsidiary of the Company, also occurred in fiscal years 2006 and 2007 in addition to fiscal years 2008, 2009 and the quarterly periods in fiscal year 2010, as previously reported, and such errors materially impacted the previously issued financial statements. The Company currently is not able to and will not be able to quantify the impact of these errors and related accounting adjustments until the completion of its internal reviews but has concluded that the previously issued financial statements should no longer be relied upon.

(Source: PR Newswire, 2011-07-08)

On March 17, 2011, the Company notified Nasdaq of its intention to voluntarily withdraw its listing application and it received immediate confirmation of the acceptance of the withdrawal. The decision to withdraw at this time resulted from the inability of the Company to satisfy Nasdaq Listing Rule 5405(a) regarding the $4.00 minimum bid price for initial listing on the Nasdaq Global Market. The voluntary withdrawal does not preclude the Company from making an application for listing on the Nasdaq Stock Market in the future. The Company's common stock will continue to be listed on the OTC Bulletin Board, under the ticker "CHME".

(Source: PR Newswire, 2011-03-23)

    see all Business Outlook notes

 Investor Presentations
2010-11-29 (HTML)   VIEW
CHME
Healthcare & Drugs

COVERAGE SUSPENDED OR TERMINATED
 
READ: Score Cards Explained
SAFETY/RISK SCORE
EXTREME RISK
DETAILS: Safety/Risk Model for CHME
Current Price:  n/a
F10k Day (2006-11-30): -100.00%$2.50
2009 Close: -100.00%$4.30
2010 Close: -100.00%$1.74
2011 Close: -100.00%$0.39
High (2012-03-15): -100.00%$0.72
Low (2012-07-09): -100.00%$0.13
Exchange:
Market Capitalization: n/a
Total Shares: 39.59 mill
Float: n/a
Avg Volume: n/a
Last Quarter: 2010-09-30
Revenue (MRQ): 17.55 mill
Net Income (MRQ): 1.66 mill
Op. Cash Flow (MRQ): -0.35 mill
all financial data provided without warranty